Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage
Xencor Inc. (NASDAQ:XNCR) is one of the best high short interest stocks with biggest upside potential.
Xencor Inc (XNCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,133,720 | $86,032,663 | 2.74% | |
| 2. | RA Capital Management Peter Kolchinsky | 4,897,237 | $59,060,678 | 0.63% | |
| 3. | EcoR1 Capital Oleg Nodelman | 2,183,000 | $26,326,980 | -33% | 1.12% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,102,106 | $13,291,398 | 0.08% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 805,421 | $9,713,377 | +59% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.12 | 53 | $1,013.36 | 5,060 | 2024-02-13 | Filing | |
| $29.87 | 12,641 | $377,586.67 | 5,090,000 | 2019-06-06 | Filing | |
| $29.87 | 14,611 | $436,407.19 | 5,077,359 | 2019-05-02 | Filing | |
| $29.77 | 3,500 | $104,195.00 | 5,062,748 | 2019-03-25 | Filing | |
| $29.96 | 2,000 | $59,920.00 | 5,059,248 | 2019-03-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.29 | 3,499 | $42,990.46 | 75,898 | 2026-04-10 | Filing | |
| $11.02 | 2,502 | $27,571.29 | 263,831 | 2026-03-06 | Filing | |
| $11.25 | 4,118 | $46,308.97 | 266,333 | 2026-03-05 | Filing | |
| $11.02 | 1,767 | $19,471.81 | 76,918 | 2026-03-06 | Filing | |
| $11.25 | 3,244 | $36,480.40 | 78,685 | 2026-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,035,918 | $157,213,171 | 0% | |
| 2. | 10,338,022 | $124,676,546 | 0.1% | |
| 3. | 6,777,461 | $81,736,180 | 0.81% | |
| 4. | 4,352,036 | $52,485,554 | 0% | |
| 5. | 3,500,342 | $42,214,125 | 0% |
News See All
11 Best High Short Interest Stocks With Biggest Upside Potential
On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on CNBC's 'Closing Bell' to discuss whether more volatility is ahead, following a volatile week in the market.
Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's Fourth Quarter and Year End 2023 Conference Call. At this time, all participants are in a listen-only mode.
Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request.
Xencor, Inc. (NASDAQ:XNCR) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's Second Quarter 2023 Conference Call. After the speakers' presentation there will be a question-and-answer session.
Xencor, Inc. (NASDAQ:XNCR) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Xencor, Inc. (NASDAQ:XNCR) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, thank you for standing by. And welcome to the Xencor's Fourth Quarter and Year End 2022 Conference Call. At this time, all participants are in a listen-only mode.
12 Best Small-Cap Healthcare Stocks To Buy Now
Macroeconomic headwinds and recessionary concerns will not weaken healthcare deals next year after the market experienced resilient mergers and acquisitions in 2022.
Hedge Fund Resource Center